Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

Building Biology Overnight: Eliminating Synthesis Bottlenecks with hands-free automated synthetic biology solutions

Presentation recording

If your discovery program is limited by the speed of your capabilities in synthesis and cloning of lead candidates, you’re not alone.

Learn how Telesis Bio’ hands-free automated BioXp® synthetic biology solutions:

  • Address workflow bottlenecks to accelerate lead discovery
  • Enable hands-free overnight synthesis of lead candidates
  • Are developing a new generation of enzymatic DNA synthesis known as SOLA (short oligonucleotide ligation assembly) to deliver robust and reproducible oligo synthesis on demand
Dan Gibson, PhD.

Dan Gibson, PhD.
Chief Technology Officer, Co-Founder
Telesis Bio

Dr. Gibson has served as Chief Technology Officer of Telesis Bio since 2018. Previously, Dr. Gibson served in various roles at Synthetic Genomics, Inc., including Principal Scientist and Vice President of DNA Technology. Since 2004, Dr. Gibson has also served as a professor at the J. Craig Venter Institute.

Contact us

The expertise of our scientists, engineers and supporting teams are at your service! Submit the form below and/or call us at 858.526.3080.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

By clicking Submit, you agree that Telesis Bio may use this information to contact you about our programs, products, or services. You may opt out at any time.

Your personal data is handled according to our privacy policy. In addition, if you are located within a distributor territory, you may be contacted directly by them.